|
Originally published In Press as doi:10.1074/jbc.M202882200 on May 9, 2002
J. Biol. Chem., Vol. 277, Issue 30, 26769-26778, July 26, 2002
Structure-Function Studies of Two Novel UDP-GlcNAc C6
Dehydratases/C4 Reductases
VARIATION FROM THE SYK DOGMA*
Carole
Creuzenet §¶,
Robert V.
Urbanic§, and
Joseph S.
Lam§
From the Department of Microbiology and Immunology,
University of Western Ontario, London, Ontario N6A 5C1, Canada and the
§ Department of Microbiology, University of Guelph, Guelph,
Ontario N1G 2W1, Canada
Received for publication, March 25, 2002, and in revised form, May 8, 2002
 |
ABSTRACT |
Two subfamilies of UDP-GlcNAc C6
dehydratases were recently identified. FlaA1, a short soluble protein
that exhibits a typical SYK catalytic triad, characterizes one of these
subfamilies, and WbpM, a large membrane protein that harbors an altered
SMK triad that was not predicted to sustain activity, represents the
other subfamily. This study focuses on investigating the structure and function of these C6 dehydratases and the role of the altered triad as
well as additional amino acid residues involved in catalysis. The
significant activity retained by the FlaA1 Y141M triad mutant and the
low activity of the WbpM M438Y mutant indicated that the methionine
residue was involved in catalysis. A Glu589 residue, which
is conserved only within the large homologues, was shown to be
essential for activity in WbpM. Introduction of this residue in FlaA1
enhanced the activity of the corresponding V266E mutant. Hence, this
glutamate residue might be responsible for the retention of catalytic
efficiency in the large homologues despite alteration of their
catalytic triad. Mutations of residues specific for the short
homologues (Asp70,
Asp149-Lys150, Cys103)
abolished the activity of FlaA1. Among them, C103M prevented dimerization but did not significantly affect the secondary structure. The fact that we could identify subfamily-specific residues that are
essential for catalysis suggested an independent evolution for each
subfamily of C6 dehydratases. Finally, the loss of activity of the
FlaA1 G20A mutant provided evidence that a cofactor is involved in
catalysis, and kinetic study of the FlaA1 H86A mutant revealed that
this conserved histidine is involved in substrate binding. None of the
mutations investigated altered the substrate, product, and function
specificity of these enzymes.
 |
INTRODUCTION |
FlaA1 and WbpM are two novel bifunctional UDP-GlcNAc C6
dehydratases/C4 reductases that were recently characterized at the biochemical level (1, 2). Both enzymes catalyze the stereo-specific conversion of UDP-GlcNAc to
Qui2NAc1 via the formation of
a 4-keto, 6-deoxy intermediate. They are both highly specific for their
substrate, UDP-GlcNAc, and exhibit no activity with closely related
substrates, such as UDP-Glc, UDP-Gal, or UDP-GalNAc, or with substrates
of other known C6 dehydratases such as GDP-mannose or dTDP-glucose.
This is consistent with the fact that, despite their dehydratase
activity, FlaA1 and WbpM exhibit very limited sequence similarity with
other known C6 dehydratases, such as GDP-D-mannose (3-6)
and dTDP- and CDP-D-glucose dehydratases (7-14). In
contrast, they are homologous to C4 epimerases such as GalE from
Escherichia coli (45% homology) (15) and WbpP from P. aeruginosa (49% homology) (16). The molecular basis
for their unexpected functional specificity is not understood to date.
Hence, FlaA1 and WbpM are representative members of a larger family of bifunctional dehydratases/reductases that is characterized by the
presence of five conserved domains organized in the same pattern (1).
One of these motifs corresponds to the signature for nucleotide-binding proteins. Another corresponds to an -helicoidal segment, where the
typical SYK catalytic triad that defines enzymes of the short chain
dehydrogenase/reductase (SDR) family is found (17-19).
Based on the size and cellular localization of the enzymes as well as
the presence or absence of a SYK catalytic triad, the family of
bifunctional dehydratases/reductases can be further divided into two
subfamilies. FlaA1 is a representative member of the subfamily of
short, soluble enzymes that possess a SYK catalytic triad. It is a
37-kDa soluble protein that is found in Helicobacter pylori
(20, 21) and has homologues in Campylobacter jejuni (22, 23)
as well as Caulobacter crescentus (24). On the contrary,
WbpM is a large (75-kDa) membrane protein (2) that exhibits an altered
catalytic triad composed of SMK residues. WbpM is found in
Pseudomonas aeruginosa (25-27) and has homologues in
numerous medically relevant bacteria, including Bordetella pertussis (WlpL) (28), Yersinia enterocolitica serotype
O:3 (WbcP) (29), and Staphylococcus aureus (CapD) (30-32).
WbpM is the only enzyme of this subfamily that has been characterized at the biochemical level. In addition, these large homologues have been
shown to be essential for the production of surface carbohydrates that
contain Qui2NAc or a derivative and are all associated with
bacterial virulence. Understanding their mechanism of action is a
prerequisite to the rational design of inhibitors with high specificity
toward these enzymes and a broad spectrum of activity against all of
the bacteria that harbor the homologues.
In the ever expanding SDR protein family, the level of identity between
enzymes is rather low (15-30%), and the tyrosine of the catalytic
triad has been observed as one of the few absolutely conserved residues
(17). Functional and structural studies of C4 epimerases and of other
SDR enzymes (15, 33-35) have confirmed that the SYK triad found in
enzymes of the SDR family plays an essential role in the formation of
the 4-keto intermediate, a reaction step shared by most members of the
SDR enzymes, notwithstanding their ultimate biochemical function (4, 9,
33, 34, 36). In particular, the tyrosine residue acts as a catalytic
base that allows the transfer of a hydrogen atom from the 4'-hydroxyl
of the sugar ring to an acceptor nucleotide cofactor such as
NAD+ or NADP+ (15, 33, 37-39). In agreement
with the widely accepted "SYK dogma," alteration of the tyrosine
residue in the catalytic triad has resulted in inactive mutants as seen
in the UDP-Gal C4 epimerase GalE S124A/Y149F and Y149F mutants (34, 35)
or in other SDR enzymes (17, 40). At most, 0.25% of wild-type
catalytic activity was reported using a Y/C dehydrogenase mutant (41).
Such an essential role of the tyrosine in the catalytic triad was also confirmed in the case of C6 dehydratases (9, 12). Hence, it is
intriguing that WbpM and its large homologues have the capacity to
perform catalysis via the formation of a 4-keto intermediate, since
they contain an altered catalytic triad lacking the central tyrosine.
This suggests that, in this subfamily of UDP-GlcNAc C6 dehydratases,
another residue must assume the role of the catalytic base and/or that
the catalytic mechanism involved might be slightly different. A
site-directed mutagenesis approach was used to investigate the role of
the tyrosine and methionine residues in the SYK and SMK catalytic
triads present in FlaA1 and WbpM, respectively. The catalytic role of
charged residues specific for each subfamily was also investigated.
Also, FlaA1 and WbpM exhibit the GXXGXXG
signature for nucleotide binding proteins and also share a conserved
alternating -helicoidal/ -sheeted secondary structure that, in SDR
proteins, delineates a Rossmann fold essential for nucleotide cofactor
binding. The importance of this fingerprint sequence for nucleotide
cofactor binding and activity has been demonstrated previously by the
abolition of protein activity by single point mutations (42-44).
Previous studies indicated that FlaA1, like C4 epimerases and unlike
other C6 dehydratases, might recycle an internal nucleotide cofactor during catalysis, but no evidence for the existence of a bound cofactor
could be obtained (1). Site-directed mutagenesis of residues
potentially involved in Rossmann fold formation and cofactor binding
was performed in FlaA1 to address this question.
Finally, most C4 epimerases and C6 dehydratases have been shown to
exist as dimers and tetramers under physiological conditions, but the
importance of oligomerization for activity is not fully understood (10,
12, 17, 45, 46). Previous studies on dehydrogenases, epimerases, and
dehydratases showed that the interactions between subunits involved
mostly the N-terminal moiety of the proteins and more specifically the
conserved long -helices 4 and 5 (17, 44, 47). For clarity, these
helices correspond to amino acid residues 97-120 and 140-160 in FlaA1
based on secondary structure prediction using the ExPASy molecular
biology software (available on the World Wide Web at www.expasy.ch).
Because the N-terminal moiety of SDR enzymes is also devoted to
cofactor binding, it is possible that oligomerization and cofactor
binding are interdependent. Each subunit possesses its own
cofactor-binding site, so that nucleotide cofactor binding should be
stoichiometric with the amount of enzyme if it is independent of
oligomerization. However, several studies report a stoichiometry of 1 molecule of cofactor per dimer of protein (12, 15, 46, 48), implying
that dimerization might promote cofactor binding and hence be essential
for activity. Moreover, the helix 5 that is involved in oligomerization
contains the tyrosine and lysine residues of the catalytic triad.
Hence, it is possible that participation of this helix in oligomer
formation results in a slightly different structure at the level of the catalytic site, which could also have a significant effect on the
activity. Consistent with this hypothesis is the observation that some
SDR proteins crystallize as a dimer in an asymmetric unit, where
substantial differences have been observed between the structures of
the binding sites of two monomers (39), suggesting that dimerization
might be responsible for fine tuning of the active site configuration.
Hence, cofactor binding and oligomerization might be interconnected
phenomena that affect enzymatic activity. In the case of FlaA1, the
formation of a dimer under physiological conditions has been described
previously, but the residues essential for the process have not been
identified (1). In FlaA1 and other short homologues, the -helix 4, which is potentially involved in dimerization, contains two conserved
cysteine residues (Cys103 and Cys118). Their
potential role for dimerization and stabilization of protein structure
was investigated by site-directed mutagenesis.
This report presents the structure-function characterization of mutants
of FlaA1 and WbpM with a view to explain their particular biochemical
and catalytic properties. The effects of the mutations on protein
structure and dimerization were investigated by circular dichroism,
fluorescence spectroscopy, and gel filtration chromatography. The
substrate specificity and physico-kinetic characteristics of each
mutant were determined by capillary electrophoresis analysis of the
reaction products. The results reveal novel essential catalytic residues and provide the basis for understanding the mechanism of
action of these dehydratases/reductases that are devoid of the usual
SYK triad.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Unless stated otherwise, all chemical reagents
used were from Sigma, and all cloning was performed in E. coli DH5 . All of the kits or enzymes were used following the
manufacturers' instructions. Protein quantitation was performed using
the BCA reagent (Pierce).
Site-directed Mutagenesis--
Site-directed mutagenesis was
performed using the QuikChangeTM procedure (Stratagene, La
Jolla, CA) with modifications according to Wang and Malcolm (49).
Complementary oligonucleotide primers were designed according to the
manufacturer's instructions, and codons that resulted in minimal
mispairing were used to introduce the desired mutations (Table
I). The templates for mutagenesis were
His-FlaA1-pET and His-S262-pET. S262 corresponds to a soluble truncated
version of WbpM where the four N-terminal transmembrane domains have
been removed (2). For clarity, WbpM refers to the soluble truncated
form S262 throughout this study. In both templates, the gene of
interest was cloned into a pET23 derivative (50) in the presence of an
N-terminal hexahistidine tag (1, 2). After mutagenesis, DNA sequencing
was performed on each mutant construct to confirm the presence of the
desired mutations and exclude the existence of any unwanted secondary
mutation. DNA sequencing was performed at the Laboratory Services
Division of the University of Guelph.
Purification of Recombinant Proteins--
Proper clones carrying
the desired mutations were transformed into CaCl2-competent
E. coli BL21(DE3)pLysS, and protein expression was carried
out as described previously (1, 2). In some cases, conditions for
protein expression were modified to circumvent the production of mutant
proteins as inclusion bodies. Incubations were performed at 30 °C
instead of 37 °C, and growth was performed in Tryptone/phosphate
medium (51) instead of Terrific broth. The concentration of the
inducer isopropyl-1-thio- -D-galactopyranoside varied from 0.15 to 1 mM. The wild-type and mutant proteins were purified by low
pressure nickel chelation chromatography as described elsewhere (1).
The fractions containing pure protein were pooled, dialyzed against 50 mM Tris-HCl buffer, adjusted to pH 7, and concentrated
using polyethylene glycol 8000 before use for activity assays.
Activity Assays and Capillary Electrophoresis Analysis of the
Reaction Products--
Typically, reactions were carried out using
0.75 mM UDP-GlcNAc as a substrate. For WbpM and its
mutants, 0.14 mM of NAD+ was added to the
reactions. The reactions were incubated in 20 mM Tris, pH
7, at 37 °C, for FlaA1 and its mutants, or in bis-Tris-propane, pH
10, at 30 °C for WbpM and its mutants. The specific composition of
each reaction mix and the reaction time are indicated in the legend of
each figure. For the determination of kinetic parameters, reactions
were performed in a total volume of 70 µl with 0.7-3.8 µg of pure
enzyme. Incubations were performed at the optimum pH and temperature
determined for each mutant as indicated in Table II. To account for the high and low
Km for UDP-GlcNAc of WbpM and FlaA1, respectively,
the substrate concentration varied from 0.05 to 3.5 mM for
mutants of WbpM and from 0.02 to 1.5 mM for mutants of
FlaA1. The reactions were quenched by boiling for 6 min. To investigate
the substrate specificity, UDP-GlcNAc was replaced by UDP-Glc, UDP-Gal,
UDP-GalNAc, GDP-mannose, or dTDP-Glc.
Capillary electrophoresis (CE) analysis of the reaction products was
performed as described elsewhere (2).
Determination of the Km for NADH for the H86A Mutant
of FlaA--
Determination of the Km for NADH was
performed spectrophotometrically as the variation of
A340 over time as described previously (1).
Analysis of the Secondary Structure of the Mutants by CD--
CD
analyses were performed on a Jasco J-600 spectropolarimeter (Easton,
MD) using a 0.1-cm cell. Three spectra recorded between 190 and 250 nm
were averaged for each measurement. Acquisition was performed with a
step of 0.2 nm. The samples were dialyzed in 50 mM sodium
phosphate buffer at pH 7 and adjusted to the appropriate pH by the
addition of concentrated stock buffer solutions before use. The samples
were then centrifuged at 12,000 × g for 20 min at
4 °C, and the supernatant was used for spectroscopic analysis. The
protein concentration was adjusted to 0.1 mg/ml as determined by the
BCA assay.
Protein Fluorescence Analysis--
Fluorescence spectra were
recorded on a Photon Technology International Alphascan fluorimeter
(Lawrenceville, NJ) using FelixTM version 1.21 software. A 75-µl cell with a 3-mm-long path was used for all
experiments. The excitation and emission slits were set on 4 and 12 nm,
respectively. The excitation wavelength was 295 nm. The proteins were
prepared at a concentration of 0.1 mg/ml in 100 mM sodium
phosphate buffer, pH 7, 100 mM NaCl.
 |
RESULTS |
Protein Expression and Purification--
Since WbpM is a large
membrane protein, a short soluble version that was previously
engineered and shown to be enzymatically equivalent to full-length WbpM
(2) was used to derive all of the WbpM mutants described in this study.
As reported previously, the expression of FlaA1 and WbpM as soluble
proteins could only be achieved if the bacteria were grown in rich
medium (Terrific broth) and if expression was carried out at
37 °C (1, 2). In several cases, the mutation of a single amino acid
was enough to trigger the production of totally insoluble protein
(Table II). Different conditions for protein expression had to be
established to obtain high enough yields of soluble mutant proteins.
For example, the H86A and D70A mutants of FlaA1 described below could
only be obtained in a soluble form after expression in
Tryptone/phosphate medium at 30 °C. Although more closely
related to the wild-type enzyme than the H86A mutant, the H86F
counterpart could not be obtained as a soluble protein under any of the
conditions tested. Similarly, no suitable expression conditions could
be found to express the FlaA1 D70N and C118M mutants as soluble
proteins, which hampered their characterization. All soluble proteins
were purified to homogeneity by metal chelation before use for activity assays or biophysical analysis (data not shown).
Role of Conserved Cysteine Residues Found in the Subfamily of Short
Homologues--
FlaA1 and its short homologues exhibit two conserved
cysteines that are not found in the large membrane homologues. They are found within an -helix predicted to be part of the dimer interface in wild-type enzyme. Their role for enzymatic activity, protein dimerization, and structural stability was examined by constructing single mutants of FlaA1 where each cysteine was replaced by a methionine residue. Out of the two resulting mutants, C103M and C118M,
only C103M could be expressed as a soluble protein. However, it was
found to be totally inactive after purification (Table II).
As judged by circular dichroism analysis, the secondary structure of
the cysteine mutant was not affected by the mutation (Fig.
1). The CD spectrum was nearly
superimposable to that of wild-type FlaA1. Nevertheless, gel filtration
chromatography showed that this mutant had lost its ability to form a
dimer, since the protein was recovered in a fraction corresponding to
an exclusion size of 37 kDa, clearly well resolved from any potential
74-kDa dimer. This suggested a potential role of this cysteine in the dimerization process. However, SDS-PAGE analysis of the wild-type protein prepared in the presence or absence of reducing agents showed
that dimerization was not due to the formation of intermolecular covalent bonds (data not shown). These results suggest that the cysteine residue might contribute to stabilization of the protein structure in a tertiary configuration suitable for dimerization rather
than be involved in covalent binding between two subunits. This
interpretation is consistent with the result of tryptophan fluorescence
analysis, which revealed subtle structural variations that were not
detected by circular dichroism analysis. The maximum emission
wavelength of FlaA1 was shifted from 347 to 359 nm upon introduction of
the C103M mutation (Fig. 2). This
indicated that the two tryptophan residues (Trp207 and
Trp322) found in FlaA1 were exposed to a more polar
environment in the mutant enzyme than in the wild-type protein,
probably reflecting the absence of dimerization or subtle variation in
the tertiary structure of the protein.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Far ultraviolet circular dichroism of FlaA1
and its mutants. Samples were prepared at a concentration of 0.1 mg/ml in 50 mM
NaH2HPO4/Na2HPO4 buffer
at pH 7. Represented spectra are the average of three scans.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 2.
Fluorescence emission spectra of FlaA1 and
its mutants. Samples were prepared at a concentration of 0.1 mg/ml
in 100 mM
NaH2HPO4/Na2HPO4 plus
100 mM NaCl buffer at pH 7. Each spectrum is an average of
three scans. The excitation wavelength used was 295 nm.
|
|
Mutagenesis of Residues Potentially Involved in the Binding of the
Nucleotide Co-factor--
FlaA1 and WbpM both exhibit the
GXXGXXG signature for NAD(P)+-binding
enzymes. The addition of exogenous cofactor was necessary to obtain
full activity of WbpM. In contrast, FlaA1 was fully active in the
absence of exogenous cofactor, although no internally bound cofactor
could be detected spectrophotometrically. To investigate whether FlaA1
indeed binds a cofactor, the glycine residue central to the
GXXGXXG motif was mutated to an alanine residue.
The resulting G20A mutant could be expressed in a soluble form and
purified to homogeneity (data not shown), although its solubility was
slightly reduced compared with wild-type FlaA1 (Table II). This mutant was totally inactive as judged by CE analysis, and activity could not
be recovered by the addition of exogenous cofactor. This suggested that
the loss of activity was not simply due to a slight reduction of
affinity for the cofactor but might be due to structural alterations of
the nucleotide-binding site.
Circular dichroism analysis revealed differences at the secondary
structure level. The CD spectrum of the G20A mutant still exhibited the
main features of the wild-type enzyme, with main peaks of ellipticities
at 193, 209, and 222 nm (Fig. 1). This indicated that the global
secondary structure of the protein was not dramatically altered.
However, the decreased intensities observed suggested that the protein
structure was not entirely identical to that of the wild-type enzyme.
This was confirmed by tryptophan fluorescence analysis that showed a
significant 8-nm shift of the protein fluorescence spectrum toward
higher wavelengths upon introduction of the G20A mutation (Fig. 2).
This indicates a more polar environment of the protein's tryptophan
residues. The fluorescence spectrum also exhibits a shoulder at 385 nm
that was not present in the wild-type spectrum. Hence, the variations
in secondary structure detected by CD in the G20A mutant also resulted
in subtle modifications of the protein tertiary and/or quaternary
structure as detected by fluorescence. Because the site of mutation
lies within the signature for the Rossmann fold that is necessary for cofactor binding, it is likely that the loss of activity observed in
this mutant reflects its inability to bind the cofactor due to slight
alterations of the tertiary structure of the Rossmann fold. This result
indicates that the integrity of the nucleotide-binding site is critical
for catalysis and confirms the participation of a cofactor in the reaction.
Based on previous work, which indicated that a conserved histidine was
essential for cofactor binding in all C4 epimerase (52), and based on
the high level of sequence conservation between C4 epimerases and
FlaA1, the potential role of the conserved His86 in
cofactor binding was investigated in FlaA1. This histidine was mutated
into a phenylalanine or an alanine residue in FlaA1 (Table II). The
H86F mutant could not be expressed in a soluble form under any of the
experimental conditions tested, and its analysis was not pursued any
further. Another mutant, H86A, was soluble and was purified by metal
chelation affinity chromatography. Spectroscopic analysis (Figs. 1 and
2) revealed structural modifications reminiscent of those observed for
the G20A mutant. However, H86A still exhibited significant catalytic
activity (Fig. 3), suggesting that the
structural alterations were limited. The levels of substrate conversion
were lower than those obtained with wild-type enzyme at equilibrium
(Fig. 4). This lower catalytic efficiency
was due to a reduced affinity of the enzyme for its substrate, as shown by the 3-fold increase in the Km of the mutant
compared with that of wild-type enzyme (Table
III). The catalytic constant kcat was only slightly lower than that of
wild-type enzyme. This indicates that the histidine residue is not
directly involved in the catalytic process but is involved in substrate
binding. The lower affinity for the substrate could reflect slight
structural alterations of the substrate-binding pocket. Despite the
observed role of His86 in substrate binding, its mutation
to an alanine residue did not alter the substrate and product
specificity of the enzyme (data not shown). Consistent with the kinetic
analysis that shows no major catalytic role of the histidine residue,
the pH dependence of the H86A mutant remained very similar to that of
the wild-type enzyme (data not shown).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 3.
Capillary electrophoresis analysis of the
reaction products obtained after catalysis of UDP-GlcNAc by purified
FlaA1, WbpM, and their mutants. All reactions were performed for
3 h with 1.9 µg of enzyme and 0.75 mM UDP-GlcNAc as
the substrate. FlaA1 panel, reaction products of
FlaA1 and its mutants. Reactions were performed at pH 7 and 37 °C.
WbpM panel, reaction products of WbpM and its
mutants. Reactions were performed at pH 10 and 30 °C with 0.14 mM NAD+. Peak 1,
UDP-GlcNAc; peak 2, 4-keto, 6-deoxy intermediate;
peak 3, UDP-Qui2NAc. a.u., arbitrary
units.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 4.
Time course of UDP-GlcNAc catalysis by
purified FlaA1, WbpM, and their mutants. Reactions were performed
with 0.75 mM UDP-GlcNAc and 1.9 µg of enzyme.
FlaA1 panel, reactions performed at 37 °C, pH
7, unless otherwise stated. V266E ( ), FlaA1 ( ), Y141M, pH 10 ( ), H86A ( ), and Y141M ( ) are shown. WbpM
panel, reactions performed at 30 °C, pH 10, with 0.14 mM NAD+. Shown are WbpM ( ), M438Y ( ), and
E589V ( ).
|
|
To determine whether this histidine residue might be involved in
cofactor binding, the effect of the mutation on cofactor binding and
affinity were investigated. The addition of NAD+ had no
effect on the catalytic efficiency at equilibrium or in initial rate
conditions, as previously observed for wild-type enzyme. Since
wild-type FlaA1 has been shown previously to use exogenous NADH, the
Km and kcat of the H86A
mutant for the cofactor NADH were determined. Both parameters were
comparable with those observed for wild-type enzyme (Table
IV), indicating that, contrary to what
was predicted, this residue was not involved in interactions with the
nucleotide cofactor. This also indicated that the observed structural
alterations did not involve the cofactor-binding site. As observed in
the wild-type enzyme, the low Km of the mutant
suggested a high affinity for the cofactor. Also, the fact that the
kcat for NADH was 60 times lower than the
kcat for the substrate indicated that the
consumption of the reduced cofactor was most likely involved in the
second step of the reaction (i.e. the reduction step), as
demonstrated for the GDP-mannose dehydratase (5).
View this table:
[in this window]
[in a new window]
|
Table IV
Kinetic parameters for the affinity of FlaA1 and its H86A mutant for
NADH as established spectrophotometrically
|
|
Site-directed Mutagenesis of the Catalytic Triad in FlaA1 and
WbpM--
FlaA1 and the short homologues exhibit the typical SYK
catalytic triad found in most members of the SDR family
(Ser130-Tyr141-Lys145 in FlaA1). On
the contrary, WbpM and other large homologues possess an altered SMK
catalytic triad
(Ser427-Met438-Lys442 in WbpM)
that, according to the accepted mechanism of C6 dehydratation, should
not allow enzymatic activity. To investigate the role of the central
tyrosine and methionine, respectively, in the catalytic mechanism of
these two subfamilies of C6 dehydratases, several single mutants were
constructed (Table II). Despite conservation of the aromatic character
of the mutated residue, the FlaA1 Y141F mutant was totally inactive,
indicating an essential role of the hydroxyl side group of the tyrosine
residue for catalysis. Intriguingly, the FlaA1 Y141M mutant was
moderately but significantly active (Figs. 3 and 4) and retained ~9%
of the wild-type catalytic efficiency under the same experimental
conditions. Kinetic analysis indicated that the Y141M mutation resulted
in only a 4.5-fold reduction in affinity for the substrate
(Km = 565 µM) and in a similar
reduction of the catalytic constant (Table III).
As reported earlier, FlaA1 and WbpM exhibited drastically different
variations of their catalytic efficiency with pH: a bell-shaped curve
with an optimum at pH 7.0-7.5 for FlaA1 and an exponential increase of
activity for pH >8.5 for WbpM (1, 2) (Fig.
5). To examine the possibility that the
substitution of Tyr for Met in the catalytic triad could be responsible
for these differences, the pH dependence of the Y141M mutant was
investigated. Fig. 5 shows that the Y141M mutant that harbored a SMK
catalytic triad exhibited an exponential pH dependence similar to that
observed in wild-type WbpM. This suggested that the tyrosine residue
plays an essential role in governing the global pH dependence in this protein background. When the kinetic constant was determined under the
optimal pH conditions of the Y141M mutant, the Km for the substrate was found to be 251 µM, closer to the
wild-type level than the value determined at pH 7, and its catalytic
constant was only two-thirds that of the wild-type enzyme. Overall, in these optimal experimental conditions, the mutant retained a remarkable 42% of catalytic efficiency as compared with the wild type.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 5.
pH dependence of UDP-GlcNAc catalysis by
FlaA1 and WbpM. Reactions were performed using sodium acetate (20 mM) for pH 5-6.5 and bis-Tris propane for pH 6.5-10 at
30 °C (WbpM) or 37 °C (FlaA1 and Y141M) with 1.9 µg of
enzyme.
|
|
To investigate whether the drastic change of optimal pH observed in the
FlaA1 Y141M mutant was due to a perturbation of the secondary structure
by the introduced mutation, far UV CD spectra were recorded at
different pH for both wild type and Y141M mutant. The CD spectra of the
wild-type and mutant enzyme were nearly identical at pH 5, and no
significant change of the secondary structure was observed in either
protein from pH 5 to 9 (Fig. 6). This
ruled out the possibility that important structural variations occurred
due to the basic pH or to the introduction of the Y141M mutation.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 6.
Analysis of FlaA1 and Y141M at various pH
values using far ultraviolet circular dichroism. Samples were
prepared at a concentration of 0.1 mg/ml in 50 mM
NaH2HPO4/Na2HPO4 buffer
at pH 5 or 9.
|
|
The reverse experiment was performed to introduce a SYK catalytic triad
in WbpM. CE analysis revealed that the resulting mutant M438Y was
active (Fig. 3). Time course experiments indicated that the mutant was
much less active than the wild-type enzyme, although 100% substrate
conversion could still readily be obtained using slightly higher enzyme
concentrations (Fig. 4). This suggested a lower rate of catalysis
rather than a defect in substrate binding. This was confirmed by the
determination of its kinetic parameters that showed a 3-fold reduction
of the kcat, whereas the Km was half that of wild type (Table III). Although this mutant possessed a typical SYK catalytic triad, it still exhibited the unusual exponential pH dependence observed in wild-type WbpM (data not shown).
The substrate and product specificities of these two catalytic mutants
(Y141M in FlaA1 and M438Y in WbpM) were not changed.
Role of Conserved Charged Residues Present Only in the Subfamily of
Short Homologues--
FlaA1 and its short homologues exhibit a
conserved aspartate residue (Asp70) at a position usually
occupied by an asparagine residue in large C6 dehydratases and in C4
epimerases. Similarly, the short homologues exhibit a conserved DK
motif (Asp149-Lys150) at a position usually
occupied by Asn-Glu in the large homologues. To examine the role of
these charged residues for enzymatic activity, the mutants D70A, D70N,
D149K/K150D and DK149/150AA were constructed (Table II). The
D70N mutant protein was expressed in the form of insoluble inclusion
bodies under all conditions tested. The other mutants could be
expressed as soluble proteins, but the solubility of the purified
proteins was lower than for the wild-type FlaA1. They were all totally
inactive as judged by CE analysis (Table II). This points to the
essential role of Asp70 and
Asp149-Lys150 in the enzymatic activity of FlaA1.
The low solubility of the mutants did not allow the analysis of their
secondary structure by CD. Sufficient amounts of the D70A mutant
protein could be obtained to perform fluorescence analysis. Its
fluorescence spectrum indicated that a subtle variation in the protein
structure had occurred, since a slight decrease of the fluorescence
signal was observed compared with wild-type protein (Fig. 2). However,
these variations were limited, since no shift in the maximum emission
wavelength was detected. This indicated an important catalytic rather
than structural role of this residue.
Role of a Conserved Glutamate Residue Found Only in the Large
Homologue Subfamily--
All of the large homologues exhibit a
conserved glutamate residue close to their C terminus, including WbpM
(Glu589). In FlaA1 and its short homologues, alignments
using the LALIGN software (available on the World Wide Web at
www.expasy.ch) showed that this residue is replaced by a small
hydrophobic residue (Val266 in FlaA1), whereas in most C4
epimerases, an aromatic residue (Tyr or His) occupies this position. In
the latter enzymes, the aromatic residue was shown to interact with the
6'- and 2'-hydroxyl of the sugar moiety. It has been recently proposed
that substitution of this residue by a cysteine in the human UDP-Glc C4
epimerase allows the enzyme to accommodate an N-acetylated
substrate (53), whereas the E. coli enzyme cannot.
Consequently, the possibility that the glutamate residue found in the
large homologues would also interact with the substrate and play a role
in catalysis and/or substrate specificity was investigated. For this
purpose, a WbpM E589V mutant was constructed (Table II). Although E589V was still significantly active (Fig. 3), time course experiments suggested that its overall catalytic efficiency was lower than that of
wild-type enzyme (Fig. 4). This was confirmed by kinetic analysis that
showed that its catalytic constant was 9-fold lower than that of wild
type (Table III), indicating a critical role of Glu589 for
catalysis. Surprisingly, this mutant had a higher affinity for its
substrate as shown by its 2.5-fold lower Km value. These observations suggest that Glu589 might be part of the
substrate-binding pocket. However, contrary to what was expected, it
prevents optimal substrate binding in WbpM.
The "reverse" FlaA1 V266E mutant was constructed to investigate the
effect of the introduction of a glutamate residue at an equivalent
position in the short homologues (Table II). This mutant exhibited
significantly higher catalytic efficiency than wild-type FlaA1 (Figs. 3
and 4), mostly due to a 40% increase in its
kcat, whereas its affinity for the substrate was
unchanged (Table III).
The data reported above clearly indicate a role of this charged residue
in catalysis; thus, the effect of its introduction or removal on the pH
dependence of the enzymes was investigated. The V266E FlaA1 mutant
exhibited the typical bell-shaped pH response curve observed for
wild-type FlaA1, with only a slight shift of +0.5 pH unit. Similarly,
the pH dependence was not affected by the E589V mutation in WbpM (data
not shown).
Despite the potential role of the Glu589 and
Val266 residues in substrate binding in WbpM and FlaA1,
respectively, the substrate specificity of the enzymes was not affected
by the mutation. No activity was detected using closely related
substrates (UDP-Glc, UDP-Gal, or UDP-GalNAc) or with substrates of
other known C6 dehydratases (GDP-mannose or dTDP-glucose). Likewise,
the stereo-specificity of the reduction of the 4-keto, 6-deoxy
intermediate was totally preserved in both mutants, so that only
UDP-Qui2NAc was produced, and none of its C4 epimer UDP-FucNAc
was detected (data not shown).
 |
DISCUSSION |
Due to their intrinsic differences from other members of the SDR
family, FlaA1 and WbpM represent ideal model systems to investigate the
molecular basis for (i) function specificity (dehydratase versus epimerase), (ii) substrate specificity (UDP-GlcNAc
versus other sugar nucleotides), (iii) stereospecificity of
product formation (UDP-Qui2NAc versus the C4 epimer
UDP-FucNAc), and (iv) mechanism of action (altered catalytic triad,
role of cofactor). To understand the molecular basis for catalysis
outside the SYK dogma, several mutants were constructed by
site-directed mutagenesis in this study (Table II). Residues
potentially involved in cofactor binding and protein oligomerization
were also targeted. The residues targeted for mutagenesis were chosen
based on the crystallography data available for C4 epimerases (2, 13,
14) and related enzymes (39, 44, 47, 53-55).
FlaA1 was shown to exist as a dimer, but the role of dimerization for
activity was not determined, and the specific residues involved in the
process were not identified. In the short homologues, two conserved
cysteine residues are present in -helix 4 that is predicted to be
located at the dimerization interface between two subunits:
Cys103 and Cys118 in FlaA1. Hence, the
contribution of two conserved cysteines to dimer formation and to
protein structure stabilization was investigated by site-directed
mutagenesis. The only soluble cysteine mutant that could be obtained,
C103M, was inactive and had lost its ability to dimerize, whereas its
secondary structure was intact. These data suggest that the conserved
cysteine residue might play a role in the dimerization process via
stabilization of an intramolecular configuration that would be suitable
for dimerization. This is consistent with the protein fluorescence
analysis, which revealed that the C103M mutation increased the polarity
of the local environment of the two tryptophan residues present in the
protein (Trp207 and Trp322), despite their
remote position from Cys103 at the primary structure level.
This change of local environment could arise from variations in the
tertiary and/or quaternary structures resulting from two nonexclusive
phenomena. First, the absence of intramolecular disulfide bonds due to
the C103M mutation could result in a less compact structure with more
exposure of core residues to the aqueous buffer. Second, because the
C103M protein can no longer dimerize, the tryptophan residues that are usually buried at the protein/protein interface in the wild-type enzyme
might be exposed to the aqueous buffer in the mutant protein. Solving
the protein structure by x-ray crystallography will determine which
interpretation is correct.
A mutation was introduced in the glycine central to the
GXXGXXG signature for nucleotide-binding proteins
of FlaA1 (G20A) to determine whether a cofactor was involved in the
catalytic process. In agreement with results obtained with other
dehydratases (3, 9, 12, 46), the data concerning the G20A mutant suggest that an enzyme-bound cofactor is involved in the catalytic process. The loss of activity observed for this mutant seems to be due
to variations at the secondary and tertiary structure level. This is
consistent with improper or altered folding of the Rossmann fold that
would prevent cofactor binding. The limited secondary structure
perturbation revealed by CD analysis was unexpected, since in the case
of other enzymes that internally recycle a tightly bound cofactor, the
removal or absence of co-factor results in irreversible denaturation of
the protein (34). Only in the human GalE can the NAD+ be
readily removed without protein denaturation (39). Hence, in the case
of FlaA1, the mutation did not appear to prevent the formation of the
Rossmann fold, which would have been reflected by a drastic change of
the CD and fluorescence spectra, but rather might have affected its
size and flexibility (44). To investigate the potential correlation
between cofactor binding and dimerization, attempts were made to
determine the dimerization status of this mutant. However, its tendency
to aggregate over time prevented such analysis.
Previous chemical mutagenesis studies on a C4 epimerase implied an
interaction between a histidine residue and the cofactor, but the
specific residue involved was not identified (52). Sequence alignments
showed that His86 from FlaA1 is conserved in all C4
epimerases (33). This residue is also conserved in all known C6
dehydratases whether or not they belong to the FlaA1/WbpM subclass of
dehydratases/reductases. The possibility that His86 would
correspond to the histidine involved in cofactor binding alluded to
above was investigated. However, our results showed that this histidine
was involved in substrate binding rather than in cofactor binding. This
was unexpected, since previous crystallography data did not reveal any
proximity of this residue with the substrate. This suggests that the
participation in cofactor binding could be indirect, especially since
the H86A did not alter the substrate specificity of the enzyme.
As mentioned above, a striking feature of WbpM and its large homologues
is their capacity to perform catalysis via the formation of a 4-keto
intermediate although they contain an altered catalytic triad. Hence,
possessing two subfamilies of enzymes that exhibit the same substrate
and function specificities but differ in their catalytic triad was a
golden opportunity to investigate the mechanism involved. The
observation that Y141F mutant of FlaA1 was inactive provided convincing
evidence that the tyrosine of the triad plays a central role in
catalysis. Also, it implied that the nucleophilic character of the side
chain of the tyrosine was important for activity and not its aromatic
character. This is consistent with the participation of the tyrosine in
a charge-transfer complexation with the cofactor and substrate (35).
Intriguingly, significant activity was obtained in the Y141M mutant
that mimics the situation found in the subfamily of large homologues
represented by WbpM. The 42% catalytic efficiency retained by the
Y141M mutant is remarkable. This is the first report of a significantly
active mutant of the tyrosine central to the catalytic triad of SDR
enzymes. The activity might involve electron delocalization from
the sulfur atom of the methionine side chain. The fact that the
methionine residue found in the SMK triad of WbpM is actively involved
in the catalytic process was demonstrated using the M438Y mutant. This
mutant had a lower activity than the wild type, although it harbored
the traditional SYK triad.
The introduction of the methionine in the catalytic triad in the Y141M
mutant of FlaA1 was sufficient to induce a dramatic change of pH
dependence of the reaction. This could reflect a shift in the local
pKa within the catalytic triad, which is expected if
a residue different from tyrosine was involved in the catalysis.
Indeed, in C4 epimerases, the pKa of the tyrosine of
the catalytic triad is 6.1 (e.g. four units lower than the
corresponding value in aqueous solution (10.1)). This results in the
stabilization of the phenolic form of tyrosine within the active site
and is caused by the neighboring positive charges of the lysine residue
of the triad and of the nicotinamide ring of the cofactor (35, 56).
Mutation of the catalytic tyrosine has been shown to totally abolish
this lowering of the local pKa within the active
site (35, 56). This is similar to what was observed for the Y141M FlaA1
mutant and for wild-type WbpM, which do not have a catalytic tyrosine
residue and have optimum activity at basic pH. In addition, the
important variation of the Km of the Y141M mutant
with the pH suggests that, when present at this position, the
methionine might also be involved in direct substrate binding. This is
consistent with the mechanism proposed by Liu et al. (35,
56) whereby the residue central to the catalytic triad could trigger
direct proton abstraction from the substrate instead of only acting as
a recipient of a proton that would be preabstracted via another amino acid.
The conserved catalytic efficiency observed despite the removal of the
central tyrosine in FlaA1 or of the methionine in WbpM is consistent
with the fact that residues other than Tyr/Met are also involved in the
catalysis. The absence of pH conversion by the M438Y mutation in WbpM
suggests that a strongly charged residue can override the pH effect due
to the tyrosine in the WbpM background. The sequences of both
subfamilies of FlaA1 and WbpM homologues were analyzed for the presence
of charged residues that could potentially be involved in catalysis and
explain the significant levels of activity observed in both enzymes in
the absence of the wild-type catalytic triad. This analysis revealed
the existence of charged residues that are conserved in one of the
families but are absent in the other. Among them, the Asp70
and Asp149-Lys150 residues present only in
FlaA1 and in the short homologues and the Glu589 residue
found only in the subfamily of large homologues that exhibit an altered
catalytic triad were each found to play a critical catalytic role. In
addition, the "subfamily specificity" of the novel residues
essential for catalysis that were identified in this study suggests
that the two subfamilies of UDP-GlcNAc C6 dehydratases/C4 epimerases
have had a divergent evolution from a common ancestor. The protein
sequences have evolved so that maximum efficiency is obtained using a
specific catalytic triad within a determined protein background that
also includes subfamily-specific features (Asp70 and
Asp149-Lys150 in short homologues,
Glu589 in large homologues). This is consistent with the
early divergence described within the rest of the SDR family (17).
The 40% increase of activity observed after introduction of a
glutamate residue in FlaA1 (mutant V266E) at a position equivalent to
Glu589 in WbpM indicated that the presence of such an
acidic residue is highly beneficial for catalytic activity. The
enhanced activity observed in the V266E mutant is unequaled by any
wild-type enzyme studied, suggesting that high levels of UDP-GlcNAc
dehydration could be detrimental to the bacteria. This is
understandable, considering that UDP-GlcNAc is a common precursor for
the synthesis of several essential cellular components, including
peptidoglycan. Hence, high levels of UDP-GlcNAc dehydration might
deplete the cellular pool of UDP-GlcNAc and adversely affect
peptidoglycan biosynthesis and cell viability. Moreover, the
introduction of the glutamate residue at position Val266
does not influence substrate binding. This is different from what was
observed in C4 epimerases in which this position is usually occupied by
an aromatic or cysteine residue suspected to interact with hydroxyl
groups of the sugar moiety of the substrate (33, 37-39, 53) and
consequently play a role in substrate binding and specificity. This
could account for the differences observed with crystallography-based
data. The determination of the structures of FlaA1 and WbpM is
currently under investigation by x-ray crystallography. Comparison of
the three-dimensional structures of the proteins will determine whether
these residues are also aligned at the tertiary structure level.
The novel residues essential for catalysis that were identified in this
study are different in each enzyme subfamily. However, they are in each
case negatively charged residues (aspartate and glutamate) that might
contribute to abstraction of a proton from the sugar moiety and act as
a catalytic base. Hence, in essence, the global mechanism for the
formation of the 4-keto intermediate might be conserved between both
subfamilies and between epimerases and dehydratases, although the
specific amino acids involved might be different. In addition, these
residues occupy very different positions in the sequence of each
protein. Only the Asp149-Lys150 are in close
proximity of the catalytic triad in FlaA1, and this location would
favor the role of the aspartate as a classical base during catalysis.
However, the Asp70 residue is located in the N-terminal
half of the protein, which is usually associated with nucleotide
cofactor binding. In WbpM, the Glu589 residue is located in
the C-terminal domain of the protein associated with substrate binding
according to previous studies on C4 epimerases (33, 34). Since its
presence seems to be essential for the high activity observed in
wild-type WbpM, and since it is only found in the large homologues that
exhibit an altered catalytic triad, it is possible that this glutamate
residue acts as the proton acceptor during catalysis. This suggests
that further transfer of the removed hydrogen to the acceptor cofactor
might occur via slightly different mechanisms in each enzyme subfamily
and probably involves a relay mechanism. The determination of the
structure of both proteins and their catalytic mutants will help to
understand how the transfer occurs and will suggest additional residues
potentially involved. In particular, additional charged residues
conserved only within the family of short homologues are also likely to participate in the process.
Although this study revealed several residues that seem directly
involved in substrate binding, the substrate and stereo-specificity of
the enzymes were conserved in all mutants. Notwithstanding the
fundamental interest in understanding the molecular basis for these
specificities, it would be interesting to be able to alter the enzyme
so that it would produce UDP-FucNAc instead of UDP-Qui2NAc.
UDP-FucNAc is not commercially available, and its chemical synthesis is
not straightforward. However, this compound is necessary for the study
of transferases that are involved in the assembly of capsule or
lipopolysaccharide molecules and might be interesting targets for the
development of antimicrobial agents. Hence, its enzymatic synthesis
using a modified version of FlaA1 or WbpM would allow further studies
of lipopolysaccharide or capsule biosynthetic pathways. Ultimately,
understanding the molecular basis for substrate and function
specificity is essential for the rational design of inhibitors
active against this novel subfamily of enzymes. The highly
conserved nature of this family of enzymes in medically relevant
bacteria suggests that an inhibitor developed against one of these
enzymes is likely to exhibit a broad spectrum of antimicrobial activity
and a high level of biochemical specificity.
In conclusion, the approach of performing structure-function studies of
two novel UDP-GlcNAc C6 dehydratases/C4 reductases is a first step
toward the understanding of the catalytic properties of a new class of
dehydratases that do not follow the classical SYK dogma. The data
reveal that the differences between the two subfamilies of enzymes go
beyond their size and cellular localization. It is apparent that
fundamental differences between the two subfamilies exist at the
catalytic level. The essential catalytic role of an altered catalytic
triad was demonstrated, and additional residues that confer improved
catalytic efficiency within a specific protein background were
identified. Future x-ray crystallography data combined with the
structural and biochemical data presented in this study will aid in
understanding the contribution of these newly identified residues to
the reaction mechanism.
 |
ACKNOWLEDGEMENTS |
We thank R. Merrill and R. Yada (University
of Guelph) for assistance in performing protein fluorescence and
circular dichroism analysis, respectively.
 |
FOOTNOTES |
*
This work was supported by operating grants from the
Canadian Institute for Health Research (CIHR) (Grant MOP-14687) (to
J. S. L.) and from the Canadian Bacterial Diseases Network, a
consortium of the Federal Networks of Centres of Excellence program.
This work was also supported by the Collaborative Health Research
Projects program of the Natural Sciences and Engineering Research
Council Grant CHRPJ-251007 (to J. S. L. and C. C.) and by CIHR Grant
MMA-41558 (to J. S. L.) for the purchase of the capillary
electrophoresis instrument.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Recipient of a postdoctoral fellowship from the Canadian
Cystic Fibrosis Foundation (CCFF).
A Zellers Senior Scientist and a recipient of a Marsha Morton
Scholarship from CCFF. To whom correspondence should be addressed. Tel.: 519-824-4120 (ext. 3823); Fax: 519-837-1802; E-mail: jlam@ uoguelph.ca.
Published, JBC Papers in Press, May 9, 2002, DOI 10.1074/jbc.M202882200
 |
ABBREVIATIONS |
The abbreviations used are:
Qui2NAc, 2-acetamido-2,6-dideoxy-D-glucose (also known as
N-acetylquinovosamine);
SDR, short chain
dehydrogenase/reductase;
CE, capillary electrophoresis;
bis-Tris, 2-
[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol.
 |
REFERENCES |
| 1.
|
Creuzenet, C.,
Schur, M. J., Li, J.,
Wakarchuk, W. W.,
and Lam, J. S.
(2000)
J. Biol. Chem.
275,
34873-34880[Abstract/Free Full Text]
|
| 2.
|
Creuzenet, C.,
and Lam, J. S.
(2001)
Mol. Microbiol.
41,
1295-1310[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Sullivan, F. X.,
Kumar, R.,
Kriz, R.,
Stahl, M., Xu, G. Y.,
Rouse, J.,
Chang, X. J.,
Boodhoo, A.,
Potvin, B.,
and Cumming, D. A.
(1998)
J. Biol. Chem.
273,
8193-8202[Abstract/Free Full Text]
|
| 4.
|
Tonetti, M.,
Sturla, L.,
Bisso, A.,
Zanardi, D.,
Benatti, U.,
and De Flora, A.
(1998)
Biochimie
80,
923-931[Medline]
[Order article via Infotrieve]
|
| 5.
|
Bonin, C. P.,
Potter, I.,
Vanzin, G. F.,
and Reiter, W. D.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
2085-2090[Abstract/Free Full Text]
|
| 6.
|
Yamamoto, K.,
Katayama, I.,
Onoda, Y.,
Inami, M.,
Kumagai, H.,
and Tochikura, T.
(1993)
Arch. Biochem. Biophys.
300,
694-698[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Marolda, C. L.,
and Valvano, M. A.
(1995)
J. Bacteriol.
177,
5539-5546[Abstract/Free Full Text]
|
| 8.
|
Yoshida, Y.,
Nakano, Y.,
Nezu, T.,
Yamashita, Y.,
and Koga, T.
(1999)
J. Biol. Chem.
274,
16933-16939[Abstract/Free Full Text]
|
| 9.
|
Snipes, C. E.,
Brillinger, G. U.,
Sellers, L.,
Mascaro, L.,
and Floss, H. G.
(1977)
J. Biol. Chem.
252,
8113-8117[Abstract/Free Full Text]
|
| 10.
|
Allard, S. T.,
Giraud, M. F.,
Whitfield, C.,
Messner, P.,
and Naismith, J. H.
(2000)
Acta Crystallogr. Sect. D Biol. Crystallogr.
56,
222-225[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Yu, Y.,
Russell, R. N.,
Thorson, J. S.,
Liu, L. D.,
and Liu, H. W.
(1992)
J. Biol. Chem.
267,
5868-5875[Abstract/Free Full Text]
|
| 12.
|
He, X.,
Thorson, J. S.,
and Liu, H. W.
(1996)
Biochemistry
35,
4721-4731[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Thorson, J., Lo, S.,
and Liu, H.
(1993)
J. Am. Chem. Soc.
115,
6993-6994[CrossRef]
|
| 14.
|
Thorson, J., Lo, S.,
and Liu, H.
(1993)
J. Am. Chem. Soc.
115,
5827-5828[CrossRef]
|
| 15.
|
Frey, P. A.
(1996)
FASEB J.
10,
461-470[Abstract]
|
| 16.
|
Creuzenet, C.,
Belanger, M.,
Wakarchuk, W. W.,
and Lam, J. S.
(2000)
J. Biol. Chem.
275,
19060-19067[Abstract/Free Full Text]
|
| 17.
|
Jornvall, H.,
Persson, B.,
Krook, M.,
Atrian, S.,
Gonzalez-Duarte, R.,
Jeffery, J.,
and Ghosh, D.
(1995)
Biochemistry
34,
6003-6013[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Jornvall, H.
(1999)
Adv. Exp. Med. Biol.
463,
359-364[Medline]
[Order article via Infotrieve]
|
| 19.
|
Jornvall, H.,
Hoog, J. O.,
and Persson, B.
(1999)
FEBS Lett.
445,
261-264[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Tomb, J. F.,
White, O.,
Kerlavage, A. R.,
Clayton, R. A.,
Sutton, G. G.,
Fleischmann, R. D.,
Ketchum, K. A.,
Klenk, H. P.,
Gill, S.,
Dougherty, B. A.,
Nelson, K.,
Quackenbush, J.,
Zhou, L.,
Kirkness, E. F.,
Peterson, S.,
et al..
(1997)
Nature
388,
539-547[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Alm, R. A.,
Ling, L. S.,
Moir, D. T.,
King, B. L.,
Brown, E. D.,
Doig, P. C.,
Smith, D. R.,
Noonan, B.,
Guild, B. C.,
deJonge, B. L.,
Carmel, G.,
Tummino, P. J.,
Caruso, A.,
Uria-Nickelsen, M.,
Mills, D. M.,
Ives, C.,
Gibson, R.,
Merberg, D.,
Mills, S. D.,
Jiang, Q.,
Taylor, D. E.,
Vovis, G. F.,
and Trust, T. J.
(1999)
Nature
397,
176-180[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Parkhill, J.,
Wren, B. W.,
Mungall, K.,
Ketley, J. M.,
Churcher, C.,
Basham, D.,
Chillingworth, T.,
Davies, R. M.,
Feltwell, T.,
Holroyd, S.,
Jagels, K.,
Karlyshev, A. V.,
Moule, S.,
Pallen, M. J.,
Penn, C. W.,
Quail, M. A.,
Rajandream, M. A.,
Rutherford, K. M.,
van Vliet, A. H.,
Whitehead, S.,
and Barrell, B. G.
(2000)
Nature
403,
665-668[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Szymanski, C. M.,
Yao, R.,
Ewing, C. P.,
Trust, T. J.,
and Guerry, P.
(1999)
Mol. Microbiol.
32,
1022-1030[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Leclerc, G.,
Wang, S. P.,
and Ely, B.
(1998)
J. Bacteriol.
180,
5010-5019[Abstract/Free Full Text]
|
| 25.
|
Burrows, L. L.,
Charter, D. F.,
and Lam, J. S.
(1996)
Mol. Microbiol.
22,
481-495[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Belanger, M.,
Burrows, L. L.,
and Lam, J. S.
(1999)
Microbiology
145,
3505-3521[Abstract/Free Full Text]
|
| 27.
|
Dean, C. R.,
Franklund, C. V.,
Retief, J. D.,
Coyne, M. J., Jr.,
Hatano, K.,
Evans, D. J.,
Pier, G. B.,
and Goldberg, J. B.
(1999)
J. Bacteriol.
181,
4275-4284[Abstract/Free Full Text]
|
| 28.
|
Allen, A.,
and Maskell, D.
(1996)
Mol. Microbiol.
19,
37-52[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Skurnik, M.,
Venho, R.,
Toivanen, P.,
and al-Hendy, A.
(1995)
Mol. Microbiol.
17,
575-594[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Lin, W. S.,
Cunneen, T.,
and Lee, C. Y.
(1994)
J. Bacteriol.
176,
7005-7016[Abstract/Free Full Text]
|
| 31.
|
Sau, S.,
and Lee, C. Y.
(1996)
J. Bacteriol.
178,
2118-2126[Abstract/Free Full Text]
|
| 32.
|
Sau, S.,
Bhasin, N.,
Wann, E. R.,
Lee, J. C.,
Foster, T. J.,
and Lee, C. Y.
(1997)
Microbiology
143,
2395-2405[Abstract/Free Full Text]
|
| 33.
|
Thoden, J. B.,
Frey, P. A.,
and Holden, H. M.
(1996)
Biochemistry
35,
5137-5144[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Thoden, J. B.,
and Holden, H. M.
(1998)
Biochemistry
37,
11469-11477[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Liu, Y.,
Thoden, J. B.,
Kim, J.,
Berger, E.,
Gulick, A. M.,
Ruzicka, F. J.,
Holden, H. M.,
and Frey, P. A.
(1997)
Biochemistry
36,
10675-10684[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Ginsburg, V.
(1961)
J. Biol. Chem.
236,
2389-2393[Free Full Text]
|
| 37.
|
Thoden, J. B.,
Frey, P. A.,
and Holden, H. M.
(1996)
Protein Sci.
5,
2149-2161[Medline]
[Order article via Infotrieve]
|
| 38.
|
Thoden, J. B.,
Frey, P. A.,
and Holden, H. M.
(1996)
Biochemistry
35,
2557-2566[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Thoden, J. B.,
Wohlers, T. M.,
Fridovich-Keil, J. L.,
and Holden, H. M.
(2000)
Biochemistry
39,
5691-5701[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Rosano, C.,
Bisso, A.,
Izzo, G.,
Tonetti, M.,
Sturla, L., De,
Flora, A.,
and Bolognesi, M.
(2000)
J. Mol. Biol.
303,
77-91[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Chen, Z.,
Jiang, J. C.,
Lin, Z. G.,
Lee, W. R.,
Baker, M. E.,
and Chang, S. H.
(1993)
Biochemistry
32,
3342-3346[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Coleman, W. G., Jr.,
and Leive, L.
(1979)
J. Bacteriol.
139,
899-910[Abstract/Free Full Text]
|
| 43.
|
Vaara, M.
(1993)
Antimicrob. Agents Chemother.
37,
354-356[Abstract/Free Full Text]
|
| 44.
|
Deacon, A. M., Ni, Y. S.,
Coleman, W. G., Jr.,
and Ealick, S. E.
(2000)
Struct. Fold Des.
8,
453-462[Medline]
[Order article via Infotrieve]
|
| 45.
|
Thompson, M. W.,
Strohl, W. R.,
and Floss, H. G.
(1992)
J. Gen. Microbiol.
138,
779-786[Abstract/Free Full Text]
|
| 46.
|
Bisso, A.,
Sturla, L.,
Zanardi, D., De,
Flora, A.,
and Tonetti, M.
(1999)
FEBS Lett.
456,
370-374[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Rizzi, M.,
Tonetti, M.,
Vigevani, P.,
Sturla, L.,
Bisso, A.,
Flora, A. D.,
Bordo, D.,
and Bolognesi, M.
(1998)
Structure
6,
1453-1465[Medline]
[Order article via Infotrieve]
|
| 48.
|
Wang, S. F.,
and Gabriel, O.
(1969)
J. Biol. Chem.
244,
3430-3437[Abstract/Free Full Text]
|
| 49.
|
Wang, W.,
and Malcolm, B. A.
(1999)
BioTechniques
26,
680-682[Medline]
[Order article via Infotrieve]
|
| 50.
|
Newton, D. T.,
and Mangroo, D.
(1999)
Biochem. J.
339,
63-69
|
| 51.
|
Moore, J. T.,
Uppal, A.,
Maley, F.,
and Maley, G. F.
(1993)
Protein Expression Purif.
4,
160-163[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Mukherji, S.,
and Bhaduri, A.
(1992)
J. Biol. Chem.
267,
11709-11713[Abstract/Free Full Text]
|
| 53.
|
Thoden, J. B.,
Wohlers, T. M.,
Fridovich-Keil, J. L.,
and Holden, H. M.
(2001)
J. Biol. Chem.
276,
15131-15136[Abstract/Free Full Text]
|
| 54.
|
Somers, W. S.,
Stahl, M. L.,
and Sullivan, F. X.
(1998)
Structure
6,
1601-1612[Medline]
[Order article via Infotrieve]
|
| 55.
|
Thoden, J. B.,
Wohlers, T. M.,
Fridovich-Keil, J. L.,
and Holden, H. M.
(2001)
J. Biol. Chem.
276,
20617-20623[Abstract/Free Full Text]
|
| 56.
|
Liu, Y.,
Vanhooke, J. L.,
and Frey, P. A.
(1996)
Biochemistry
35,
7615-7620[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Coyne, M. Chatzidaki-Livanis, L. C. Paoletti, and L. E. Comstock
Role of glycan synthesis in colonization of the mammalian gut by the bacterial symbiont Bacteroides fragilis
PNAS,
September 2, 2008;
105(35):
13099 - 13104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. A. Knirel, O. V. Bystrova, N. A. Kocharova, U. Zahringer, and G. B. Pier
Review: Conserved and variable structural features in the lipopolysaccharide of Pseudomonas aeruginosa
Innate Immunity,
December 1, 2006;
12(6):
324 - 336.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ishiyama, C. Creuzenet, W. L. Miller, M. Demendi, E. M. Anderson, G. Harauz, J. S. Lam, and A. M. Berghuis
Structural Studies of FlaA1 from Helicobacter pylori Reveal the Mechanism for Inverting 4,6-Dehydratase Activity
J. Biol. Chem.,
August 25, 2006;
281(34):
24489 - 24495.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. F. Mulrooney, K. K. H. Poon, D. J. McNally, J.-R. Brisson, and J. S. Lam
Biosynthesis of UDP-N-acetyl-L-fucosamine, a Precursor to the Biosynthesis of Lipopolysaccharide in Pseudomonas aeruginosa Serotype O11
J. Biol. Chem.,
May 20, 2005;
280(20):
19535 - 19542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Merkx-Jacques, R. K. Obhi, G. Bethune, and C. Creuzenet
The Helicobacter pylori flaA1 and wbpB Genes Control Lipopolysaccharide and Flagellum Synthesis and Function
J. Bacteriol.,
April 15, 2004;
186(8):
2253 - 2265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Forsberg, K. D. Noel, J. Box, and R. W. Carlson
Genetic Locus and Structural Characterization of the Biochemical Defect in the O-Antigenic Polysaccharide of the Symbiotically Deficient Rhizobium etli Mutant, CE166: REPLACEMENT OF N-ACETYLQUINOVOSAMINE WITH ITS HEXOSYL-4-ULOSE PRECURSOR
J. Biol. Chem.,
December 19, 2003;
278(51):
51347 - 51359.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|